Machine learning-based integration of network features and chemical structure of compounds for SARS‐CoV‐2 drug effect analysis

• Egile Nagusiak: Julian Späth (Egilea), Rui‐Sheng Wang (Egilea), Maeve Humphrey (Egilea), Jan Baumbach (Egilea), Joseph Loscalzo (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2024-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract High drug development costs and the limited number of new annual drug approvals increase the need for innovative approaches for drug effect prediction. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the cause of coronavirus disease 2019 (COVID‐19), led to a global pandemic wi...